May 23, 2016.
Three of Sanofi's (Paris, France) top executives are leaving the company as its "2020 strategic roadmap" gets under way.
Pascale Witz, executive vice president of diabetes and cardiovascular, Carsten Hellmann, executive vice president of Merial, Sanofi’s animal health division, and Suresh Kumar, executive vice president of external affairs, have announced their intention to leave the company.
Hellmann has accepted a position as president and CEO of ALK (Horsholm, Denmark).
Plan Ahead: Mastering Your AI Budget for 2025 Success
October 9th 2024Generative AI is just one part of the artificial intelligence and machine learning that is being used by life science organizations, emerging as a major area of interest and an area in which costs and ROI are still largely unknown.